Brick by brick: metabolism and tumor cell growth.

c-Myc suppression of miR-23a/b enhances mitochondrial glutaminase expression and glutamine metabolism. Nature (2009) 13.28

Oncogenic Kras maintains pancreatic tumors through regulation of anabolic glucose metabolism. Cell (2012) 7.36

The nuts and bolts of AGC protein kinases. Nat Rev Mol Cell Biol (2010) 6.91

The transcription factor Myc controls metabolic reprogramming upon T lymphocyte activation. Immunity (2011) 6.00

Q's next: the diverse functions of glutamine in metabolism, cell biology and cancer. Oncogene (2009) 5.81

Analysis of cancer metabolism by imaging hyperpolarized nuclei: prospects for translation to clinical research. Neoplasia (2011) 5.53

Monoacylglycerol lipase regulates a fatty acid network that promotes cancer pathogenesis. Cell (2010) 5.47

p53 and metabolism. Nat Rev Cancer (2009) 5.05

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression. Proc Natl Acad Sci U S A (2010) 4.97

Glucose-independent glutamine metabolism via TCA cycling for proliferation and survival in B cells. Cell Metab (2012) 4.80

MYC-induced cancer cell energy metabolism and therapeutic opportunities. Clin Cancer Res (2009) 4.32

Phosphate-activated glutaminase (GLS2), a p53-inducible regulator of glutamine metabolism and reactive oxygen species. Proc Natl Acad Sci U S A (2010) 4.18

Pyruvate kinase M2 regulates gene transcription by acting as a protein kinase. Mol Cell (2012) 3.98

Fueling immunity: insights into metabolism and lymphocyte function. Science (2013) 3.62

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence. Nature (2013) 3.46

Pyruvate carboxylase is required for glutamine-independent growth of tumor cells. Proc Natl Acad Sci U S A (2011) 3.39

Serine, glycine and one-carbon units: cancer metabolism in full circle. Nat Rev Cancer (2013) 3.23

Glioblastoma cells require glutamate dehydrogenase to survive impairments of glucose metabolism or Akt signaling. Cancer Res (2009) 3.15

Mammalian target of rapamycin up-regulation of pyruvate kinase isoenzyme type M2 is critical for aerobic glycolysis and tumor growth. Proc Natl Acad Sci U S A (2011) 3.14

Dysregulated pH: a perfect storm for cancer progression. Nat Rev Cancer (2011) 3.10

Regulation of immune responses by mTOR. Annu Rev Immunol (2011) 3.08

Targeting cellular metabolism to improve cancer therapeutics. Cell Death Dis (2013) 3.07

Cancer cell metabolism: one hallmark, many faces. Cancer Discov (2012) 3.03

Cellular metabolism and disease: what do metabolic outliers teach us? Cell (2012) 2.90

Analysis of tumor metabolism reveals mitochondrial glucose oxidation in genetically diverse human glioblastomas in the mouse brain in vivo. Cell Metab (2012) 2.86

Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci U S A (2013) 2.57

The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev (2009) 2.54

Regulation of intermediary metabolism by protein acetylation. Trends Biochem Sci (2010) 2.36

A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol (2012) 2.35

Anti-apoptotic MCL-1 localizes to the mitochondrial matrix and couples mitochondrial fusion to respiration. Nat Cell Biol (2012) 2.25

Probing the stochastic, motor-driven properties of the cytoplasm using force spectrum microscopy. Cell (2014) 2.23

Erk regulation of pyruvate dehydrogenase flux through PDK4 modulates cell proliferation. Genes Dev (2011) 2.20

Evaluation of 13C isotopic tracers for metabolic flux analysis in mammalian cells. J Biotechnol (2009) 2.08

Cancer metabolism: current perspectives and future directions. Cell Death Dis (2012) 2.07

O-GlcNAc signaling: a metabolic link between diabetes and cancer? Trends Biochem Sci (2010) 2.05

Metabolic switching and fuel choice during T-cell differentiation and memory development. Immunol Rev (2012) 2.03

TIGAR is required for efficient intestinal regeneration and tumorigenesis. Dev Cell (2013) 2.03

Tumor metabolism: cancer cells give and take lactate. J Clin Invest (2008) 1.97

Heterogeneity of tumor-induced gene expression changes in the human metabolic network. Nat Biotechnol (2013) 1.91

Metformin prevents liver tumorigenesis by inhibiting pathways driving hepatic lipogenesis. Cancer Prev Res (Phila) (2012) 1.90

Inhibition of mitochondrial fission prevents cell cycle progression in lung cancer. FASEB J (2012) 1.80

Understanding the Warburg effect and the prognostic value of stromal caveolin-1 as a marker of a lethal tumor microenvironment. Breast Cancer Res (2011) 1.80

p53 regulation of metabolic pathways. Cold Spring Harb Perspect Biol (2009) 1.79

Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem Biol (2011) 1.74

Caspase-independent cell death: leaving the set without the final cut. Oncogene (2008) 1.74

Serine and glycine metabolism in cancer. Trends Biochem Sci (2014) 1.70

Nutrient sensing, metabolism, and cell growth control. Mol Cell (2013) 1.67

Oxidation of alpha-ketoglutarate is required for reductive carboxylation in cancer cells with mitochondrial defects. Cell Rep (2014) 1.64

Critical role of O-Linked β-N-acetylglucosamine transferase in prostate cancer invasion, angiogenesis, and metastasis. J Biol Chem (2012) 1.63

Therapeutic targeting of cancer cell metabolism. J Mol Med (Berl) (2011) 1.62

Evaluation of substituted N,N'-diarylsulfonamides as activators of the tumor cell specific M2 isoform of pyruvate kinase. J Med Chem (2010) 1.61

c-Myc and cancer metabolism. Clin Cancer Res (2012) 1.60

Delving deeper: MCL-1's contributions to normal and cancer biology. Trends Cell Biol (2012) 1.60

Chemical contrast for imaging living systems: molecular vibrations drive CARS microscopy. Nat Chem Biol (2011) 1.58

Tumor glycolysis as a target for cancer therapy: progress and prospects. Mol Cancer (2013) 1.57

Oxygen consumption can regulate the growth of tumors, a new perspective on the Warburg effect. PLoS One (2009) 1.52

Is cancer a disease of abnormal cellular metabolism? New angles on an old idea. Genet Med (2008) 1.50

Metformin decreases glucose oxidation and increases the dependency of prostate cancer cells on reductive glutamine metabolism. Cancer Res (2013) 1.49

NNMT promotes epigenetic remodeling in cancer by creating a metabolic methylation sink. Nat Chem Biol (2013) 1.46

Riboneogenesis in yeast. Cell (2011) 1.43

PGC1α promotes tumor growth by inducing gene expression programs supporting lipogenesis. Cancer Res (2011) 1.43

Transcription factor NRF2 regulates miR-1 and miR-206 to drive tumorigenesis. J Clin Invest (2013) 1.42

Glutamine metabolism is essential for human cytomegalovirus infection. J Virol (2009) 1.42

Pyruvate dehydrogenase kinase as a novel therapeutic target in oncology. Front Oncol (2013) 1.42

Sildenafil increases chemotherapeutic efficacy of doxorubicin in prostate cancer and ameliorates cardiac dysfunction. Proc Natl Acad Sci U S A (2010) 1.41

Evaluation of thieno[3,2-b]pyrrole[3,2-d]pyridazinones as activators of the tumor cell specific M2 isoform of pyruvate kinase. Bioorg Med Chem Lett (2010) 1.37

A glycolytic burst drives glucose induction of global histone acetylation by picNuA4 and SAGA. Nucleic Acids Res (2009) 1.34

Natural products reveal cancer cell dependence on oxysterol-binding proteins. Nat Chem Biol (2011) 1.31

Metabolomic fingerprint reveals that metformin impairs one-carbon metabolism in a manner similar to the antifolate class of chemotherapy drugs. Aging (Albany NY) (2012) 1.31

The hormone receptor GUCY2C suppresses intestinal tumor formation by inhibiting AKT signaling. Gastroenterology (2009) 1.30

A combined proteomics and metabolomics profiling of gastric cardia cancer reveals characteristic dysregulations in glucose metabolism. Mol Cell Proteomics (2010) 1.30

Integrative genomics analysis of chromosome 5p gain in cervical cancer reveals target over-expressed genes, including Drosha. Mol Cancer (2008) 1.29

Global profiling strategies for mapping dysregulated metabolic pathways in cancer. Cell Metab (2012) 1.28

The return of metabolism: biochemistry and physiology of the pentose phosphate pathway. Biol Rev Camb Philos Soc (2014) 1.27

Nuclear targeting of 6-phosphofructo-2-kinase (PFKFB3) increases proliferation via cyclin-dependent kinases. J Biol Chem (2009) 1.27

Cancer metabolic reprogramming: importance, main features, and potentials for precise targeted anti-cancer therapies. Cancer Biol Med (2014) 1.27

Effects of a ketogenic diet on the quality of life in 16 patients with advanced cancer: A pilot trial. Nutr Metab (Lond) (2011) 1.27

Design, synthesis, and pharmacological evaluation of bis-2-(5-phenylacetamido-1,2,4-thiadiazol-2-yl)ethyl sulfide 3 (BPTES) analogs as glutaminase inhibitors. J Med Chem (2012) 1.27

Role of glutamine in cancer: therapeutic and imaging implications. J Nucl Med (2011) 1.25

Cancer research: past, present and future. Nat Rev Cancer (2011) 1.24

Inhibition of stearoyl-CoA desaturase 1 expression induces CHOP-dependent cell death in human cancer cells. PLoS One (2010) 1.24

New plays in the p53 theater. Curr Opin Genet Dev (2010) 1.19

Viral effects on metabolism: changes in glucose and glutamine utilization during human cytomegalovirus infection. Trends Microbiol (2011) 1.17

O-GlcNAcylation: A New Cancer Hallmark? Front Endocrinol (Lausanne) (2013) 1.16

Molecular basis for the differential use of glucose and glutamine in cell proliferation as revealed by synchronized HeLa cells. Proc Natl Acad Sci U S A (2011) 1.15

Loss of the tumor suppressor LKB1 promotes metabolic reprogramming of cancer cells via HIF-1α. Proc Natl Acad Sci U S A (2014) 1.14

Quantitative analysis of acetyl-CoA production in hypoxic cancer cells reveals substantial contribution from acetate. Cancer Metab (2014) 1.14

PEPCK Coordinates the Regulation of Central Carbon Metabolism to Promote Cancer Cell Growth. Mol Cell (2015) 1.14

Autophagy-related gene 12 (ATG12) is a novel determinant of primary resistance to HER2-targeted therapies: utility of transcriptome analysis of the autophagy interactome to guide breast cancer treatment. Oncotarget (2012) 1.14

Stable isotope-resolved metabolomics (SIRM) in cancer research with clinical application to nonsmall cell lung cancer. OMICS (2011) 1.13

18FDG-PET predicts pharmacodynamic response to OSI-906, a dual IGF-1R/IR inhibitor, in preclinical mouse models of lung cancer. Clin Cancer Res (2011) 1.13

Genetics and biology of pancreatic ductal adenocarcinoma. Genes Dev (2016) 1.13

p63 regulates glutaminase 2 expression. Cell Cycle (2013) 1.12

Enigmatic MYC Conducts an Unfolding Systems Biology Symphony. Genes Cancer (2010) 1.11

Metabolic reprogramming induced by ketone bodies diminishes pancreatic cancer cachexia. Cancer Metab (2014) 1.11

Targeting SREBP-1-driven lipid metabolism to treat cancer. Curr Pharm Des (2014) 1.11

New roles for pyruvate kinase M2: working out the Warburg effect. Trends Biochem Sci (2008) 1.10

Mitochondrial structure, function and dynamics are temporally controlled by c-Myc. PLoS One (2012) 1.09

Retained features of embryonic metabolism in the adult MRL mouse. Mol Genet Metab (2009) 1.09

Genetically-defined metabolic reprogramming in cancer. Trends Endocrinol Metab (2012) 1.09

On the origin of cancer cells. Science (1956) 49.55

High frequency of mutations of the PIK3CA gene in human cancers. Science (2004) 27.94

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A (2007) 15.88

TIGAR, a p53-inducible regulator of glycolysis and apoptosis. Cell (2006) 11.85

p53 regulates mitochondrial respiration. Science (2006) 9.06

ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell (2005) 7.65

Cancer's molecular sweet tooth and the Warburg effect. Cancer Res (2006) 7.24

Deficiency in glutamine but not glucose induces MYC-dependent apoptosis in human cells. J Cell Biol (2007) 6.54

Evidence that glutamine, not sugar, is the major energy source for cultured HeLa cells. J Biol Chem (1979) 6.53

Pyruvate kinase type M2 and its role in tumor growth and spreading. Semin Cancer Biol (2005) 5.25

Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell (2002) 5.06

The growth response of mammalian cells in tissue culture to L-glutamine and L-glutamic acid. J Biol Chem (1956) 4.42

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene (2005) 4.28

The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev (2007) 4.13

Glycolytic enzymes can modulate cellular life span. Cancer Res (2005) 3.78

Oncogenic PI3K and its role in cancer. Curr Opin Oncol (2006) 3.61

Cytokine stimulation promotes glucose uptake via phosphatidylinositol-3 kinase/Akt regulation of Glut1 activity and trafficking. Mol Biol Cell (2007) 3.54

Fatty acid synthesis: a potential selective target for antineoplastic therapy. Proc Natl Acad Sci U S A (1994) 3.50

Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J Biol Chem (2006) 3.45

Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes. Genomics (2004) 3.35

Perturbational profiling of a cell-line model of tumorigenesis by using metabolic measurements. Proc Natl Acad Sci U S A (2005) 3.18

Increased lipogenesis in cancer cells: new players, novel targets. Curr Opin Clin Nutr Metab Care (2006) 3.09

Aerobic glycolysis during lymphocyte proliferation. Nature (1976) 2.94

PKB/Akt induces transcription of enzymes involved in cholesterol and fatty acid biosynthesis via activation of SREBP. Oncogene (2005) 2.77

p53: new roles in metabolism. Trends Cell Biol (2007) 2.69

Oxythiamine and dehydroepiandrosterone inhibit the nonoxidative synthesis of ribose and tumor cell proliferation. Cancer Res (1997) 2.35

Inhibition of fatty acid synthesis delays disease progression in a xenograft model of ovarian cancer. Cancer Res (1996) 2.18

Inhibition of glutaminase expression by antisense mRNA decreases growth and tumourigenicity of tumour cells. Biochem J (2000) 2.17

Acetyl-CoA carboxylase alpha is essential to breast cancer cell survival. Cancer Res (2006) 2.03

RNA interference-mediated silencing of the acetyl-CoA-carboxylase-alpha gene induces growth inhibition and apoptosis of prostate cancer cells. Cancer Res (2005) 2.01

Elevated expression of fatty acid synthase and fatty acid synthetic activity in colorectal neoplasia. Am J Pathol (1997) 1.93

Glutamine and glucose metabolism during thymocyte proliferation. Pathways of glutamine and glutamate metabolism. Biochem J (1985) 1.92

Expression of transketolase TKTL1 predicts colon and urothelial cancer patient survival: Warburg effect reinterpreted. Br J Cancer (2006) 1.91

Transcriptional activities of nuclear SREBP-1a, -1c, and -2 to different target promoters of lipogenic and cholesterogenic genes. J Lipid Res (2002) 1.86

Cloning and analysis of unique human glutaminase isoforms generated by tissue-specific alternative splicing. Physiol Genomics (1999) 1.84

Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB J (2004) 1.79

Metabolism and action of amino acid analog anti-cancer agents. Pharmacol Ther (1990) 1.79

Co-expression of glutaminase K and L isoenzymes in human tumour cells. Biochem J (2005) 1.76

Metabolic profiling of cell growth and death in cancer: applications in drug discovery. Drug Discov Today (2002) 1.74

Liver and adipose tissue contributions to newly formed fatty acids in an ascites tumor. Am J Physiol (1984) 1.51

Mortality in a cohort of men expressing the glucose-6-phosphate dehydrogenase deficiency. Blood (1998) 1.48

Glutaminase isoform expression in cell lines derived from human colorectal adenomas and carcinomas. Biochem J (2003) 1.47

Estradiol stimulates the biosynthetic pathways of breast cancer cells: detection by metabolic flux analysis. Metab Eng (2006) 1.32

Glucose and glutamine metabolism in C6 glioma cells studied by carbon 13 NMR. Biochimie (1996) 1.30

Oncogenes in tumor metabolism, tumorigenesis, and apoptosis. J Bioenerg Biomembr (1997) 1.28

KGF induces lipogenic genes through a PI3K and JNK/SREBP-1 pathway in H292 cells. J Lipid Res (2005) 1.28

The effect of thiamine supplementation on tumour proliferation. A metabolic control analysis study. Eur J Biochem (2001) 1.28

Complexity and species variation of the kidney-type glutaminase gene. Physiol Genomics (2002) 1.24

Transketolase-like 1 expression correlates with subtypes of ovarian cancer and the presence of distant metastases. Int J Gynecol Cancer (2007) 1.22

Phosphate-activated glutaminase expression during tumor development. FEBS Lett (1994) 1.14

Glutaminase and glutamine synthetase activities in human cirrhotic liver and hepatocellular carcinoma. Cancer Res (1992) 1.09

Dietary control of lipogenesis in vivo in host tissues and tumors of mice bearing Ehrlich ascites carcinoma. Cancer Res (1980) 1.03

Glutamine synthetase and glutaminase activities in various hepatoma cells. Biochem Int (1989) 1.00

Cell cycle-associated expression of M2-type isozyme of pyruvate kinase in proliferating rat thymocytes. J Biol Chem (1992) 0.95

Enzymatic and immunological studies on pyruvate carboxylase in livers and liver tumors. Cancer Res (1973) 0.94

A 13C NMR study on fluxes into the TCA cycle of neuronal and glial tumor cell lines and primary cells. Biochimie (1993) 0.91

Activities of key gluconeogenic enzymes and glycogen synthase in rat and human livers, hepatomas, and hepatoma cell cultures. Cancer Res (1978) 0.90

Glucose-6-phosphate dehydrogenase deficiency and cancer in a Sardinian male population: a case-control study. Carcinogenesis (1989) 0.86

Understanding the Warburg effect: the metabolic requirements of cell proliferation. Science (2009) 49.82

An inhibitor of Bcl-2 family proteins induces regression of solid tumours. Nature (2005) 22.40

Guidelines for the use and interpretation of assays for monitoring autophagy in higher eukaryotes. Autophagy (2007) 20.92

Guidelines for the use and interpretation of assays for monitoring autophagy. Autophagy (2012) 20.08

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature (2009) 19.65

The biology of cancer: metabolic reprogramming fuels cell growth and proliferation. Cell Metab (2008) 18.87

Growth factor regulation of autophagy and cell survival in the absence of apoptosis. Cell (2005) 17.81

Beyond aerobic glycolysis: transformed cells can engage in glutamine metabolism that exceeds the requirement for protein and nucleotide synthesis. Proc Natl Acad Sci U S A (2007) 15.88

Leukemic IDH1 and IDH2 mutations result in a hypermethylation phenotype, disrupt TET2 function, and impair hematopoietic differentiation. Cancer Cell (2010) 15.20

The common feature of leukemia-associated IDH1 and IDH2 mutations is a neomorphic enzyme activity converting alpha-ketoglutarate to 2-hydroxyglutarate. Cancer Cell (2010) 13.13

Myc regulates a transcriptional program that stimulates mitochondrial glutaminolysis and leads to glutamine addiction. Proc Natl Acad Sci U S A (2008) 11.71

AMP-activated protein kinase induces a p53-dependent metabolic checkpoint. Mol Cell (2005) 11.19

Metabolic reprogramming: a cancer hallmark even warburg did not anticipate. Cancer Cell (2012) 9.88

Akt stimulates aerobic glycolysis in cancer cells. Cancer Res (2004) 9.35

Succinate links TCA cycle dysfunction to oncogenesis by inhibiting HIF-alpha prolyl hydroxylase. Cancer Cell (2005) 9.33

Autophagy inhibition enhances therapy-induced apoptosis in a Myc-induced model of lymphoma. J Clin Invest (2007) 9.33

Role of Bcl-2 family proteins in a non-apoptotic programmed cell death dependent on autophagy genes. Nat Cell Biol (2004) 8.85

ATP-citrate lyase links cellular metabolism to histone acetylation. Science (2009) 8.82

IDH1 mutation is sufficient to establish the glioma hypermethylator phenotype. Nature (2012) 8.66

IDH mutation impairs histone demethylation and results in a block to cell differentiation. Nature (2012) 7.95

ATP citrate lyase inhibition can suppress tumor cell growth. Cancer Cell (2005) 7.65

Systemic treatment with the antidiabetic drug metformin selectively impairs p53-deficient tumor cell growth. Cancer Res (2007) 7.42

Autophagy in metazoans: cell survival in the land of plenty. Nat Rev Mol Cell Biol (2005) 7.11

The CD28 signaling pathway regulates glucose metabolism. Immunity (2002) 6.65

Tumor suppressors and cell metabolism: a recipe for cancer growth. Genes Dev (2009) 6.46

Glutamine addiction: a new therapeutic target in cancer. Trends Biochem Sci (2010) 6.30

CTLA-4 and PD-1 receptors inhibit T-cell activation by distinct mechanisms. Mol Cell Biol (2005) 6.18

Alkylating DNA damage stimulates a regulated form of necrotic cell death. Genes Dev (2004) 6.08

Ulk1 plays a critical role in the autophagic clearance of mitochondria and ribosomes during reticulocyte maturation. Blood (2008) 5.43

Death by design: apoptosis, necrosis and autophagy. Curr Opin Cell Biol (2004) 5.31

Fuel feeds function: energy metabolism and the T-cell response. Nat Rev Immunol (2005) 5.29

Hypoxia promotes isocitrate dehydrogenase-dependent carboxylation of α-ketoglutarate to citrate to support cell growth and viability. Proc Natl Acad Sci U S A (2011) 5.24

Akt maintains cell size and survival by increasing mTOR-dependent nutrient uptake. Mol Biol Cell (2002) 5.06

Necrotic death as a cell fate. Genes Dev (2006) 4.93

The proapoptotic factors Bax and Bak regulate T Cell proliferation through control of endoplasmic reticulum Ca(2+) homeostasis. Immunity (2007) 4.74

AMPK regulates the circadian clock by cryptochrome phosphorylation and degradation. Science (2009) 4.72

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells. Nature (2013) 4.71

Essential regulation of cell bioenergetics by constitutive InsP3 receptor Ca2+ transfer to mitochondria. Cell (2010) 4.62

The glucose dependence of Akt-transformed cells can be reversed by pharmacologic activation of fatty acid beta-oxidation. Oncogene (2005) 4.28

Hypoxia-induced energy stress regulates mRNA translation and cell growth. Mol Cell (2006) 4.20

The transcription factor HIF-1alpha plays a critical role in the growth factor-dependent regulation of both aerobic and anaerobic glycolysis. Genes Dev (2007) 4.13

HIF and c-Myc: sibling rivals for control of cancer cell metabolism and proliferation. Cancer Cell (2007) 4.10

Toll-like receptor-induced changes in glycolytic metabolism regulate dendritic cell activation. Blood (2010) 3.98

Akt-dependent transformation: there is more to growth than just surviving. Oncogene (2005) 3.91

Akt-directed glucose metabolism can prevent Bax conformation change and promote growth factor-independent survival. Mol Cell Biol (2003) 3.84

The serine/threonine kinase Pim-2 is a transcriptionally regulated apoptotic inhibitor. Genes Dev (2003) 3.79

PKC regulates a farnesyl-electrostatic switch on K-Ras that promotes its association with Bcl-XL on mitochondria and induces apoptosis. Mol Cell (2006) 3.66

Hexokinase-mitochondria interaction mediated by Akt is required to inhibit apoptosis in the presence or absence of Bax and Bak. Mol Cell (2004) 3.62

Deficiency in Bak and Bax perturbs thymic selection and lymphoid homeostasis. Nat Immunol (2002) 3.58

Revving the engine: signal transduction fuels T cell activation. Immunity (2007) 3.57

Bax and Bak can localize to the endoplasmic reticulum to initiate apoptosis. J Cell Biol (2003) 3.52

Autophagy: basic principles and relevance to disease. Annu Rev Pathol (2008) 3.52

ATP citrate lyase is an important component of cell growth and transformation. Oncogene (2005) 3.48

Phosphatidylinositol 3-kinase-dependent modulation of carnitine palmitoyltransferase 1A expression regulates lipid metabolism during hematopoietic cell growth. J Biol Chem (2006) 3.45

The hexosamine biosynthetic pathway couples growth factor-induced glutamine uptake to glucose metabolism. Genes Dev (2010) 3.40

The roles of therapy-induced autophagy and necrosis in cancer treatment. Clin Cancer Res (2007) 3.35

Metabolic enzymes as oncogenes or tumor suppressors. N Engl J Med (2009) 3.24

The Bax subfamily of Bcl2-related proteins is essential for apoptotic signal transduction by c-Jun NH(2)-terminal kinase. Mol Cell Biol (2002) 3.08

Signaling kinase AMPK activates stress-promoted transcription via histone H2B phosphorylation. Science (2010) 3.05

Carnitine palmitoyltransferase 1C promotes cell survival and tumor growth under conditions of metabolic stress. Genes Dev (2011) 2.97

The endoplasmic reticulum gateway to apoptosis by Bcl-X(L) modulation of the InsP3R. Nat Cell Biol (2005) 2.94

Ammonia-induced autophagy is independent of ULK1/ULK2 kinases. Proc Natl Acad Sci U S A (2011) 2.91

Cellular metabolism and disease: what do metabolic outliers teach us? Cell (2012) 2.90

Akt activation promotes degradation of tuberin and FOXO3a via the proteasome. J Biol Chem (2003) 2.80

The survival kinases Akt and Pim as potential pharmacological targets. J Clin Invest (2005) 2.62

Hypoxic and Ras-transformed cells support growth by scavenging unsaturated fatty acids from lysophospholipids. Proc Natl Acad Sci U S A (2013) 2.57

Regulation of T lymphocyte metabolism. J Immunol (2004) 2.55

Metabolic regulation of epigenetics. Cell Metab (2012) 2.55

The molecular determinants of de novo nucleotide biosynthesis in cancer cells. Curr Opin Genet Dev (2009) 2.54

Distinct IL-2 receptor signaling pattern in CD4+CD25+ regulatory T cells. J Immunol (2004) 2.54

Cellular metabolic stress: considering how cells respond to nutrient excess. Mol Cell (2010) 2.50

Pathways of apoptosis in lymphocyte development, homeostasis, and disease. Cell (2002) 2.48

Ars2 regulates both miRNA- and siRNA- dependent silencing and suppresses RNA virus infection in Drosophila. Cell (2009) 2.38

A two-way street: reciprocal regulation of metabolism and signalling. Nat Rev Mol Cell Biol (2012) 2.35

Activated Akt promotes increased resting T cell size, CD28-independent T cell growth, and development of autoimmunity and lymphoma. Eur J Immunol (2003) 2.31

Ars2 links the nuclear cap-binding complex to RNA interference and cell proliferation. Cell (2009) 2.28

Therapeutic targets in cancer cell metabolism and autophagy. Nat Biotechnol (2012) 2.27

Cancer-associated IDH1 mutations produce 2-hydroxyglutarate. Nature (2010) 2.21

Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation. Proc Natl Acad Sci U S A (2012) 2.10

Pim and Akt oncogenes are independent regulators of hematopoietic cell growth and survival. Blood (2005) 2.09

Defective autophagy leads to cancer. Cancer Cell (2003) 2.08

Cell metabolism in the regulation of programmed cell death. Trends Endocrinol Metab (2002) 2.04

Induction of sarcomas by mutant IDH2. Genes Dev (2013) 2.02

The Pim kinases control rapamycin-resistant T cell survival and activation. J Exp Med (2005) 1.99

Q&A: Cancer: clues from cell metabolism. Nature (2010) 1.98

Hsp90-Cdc37 chaperone complex regulates Ulk1- and Atg13-mediated mitophagy. Mol Cell (2011) 1.91

Critical function of endogenous XIAP in regulating caspase activation during sympathetic neuronal apoptosis. J Cell Biol (2003) 1.87

The PP2A-associated protein alpha4 is an essential inhibitor of apoptosis. Science (2004) 1.80

Bax regulates primary necrosis through mitochondrial dynamics. Proc Natl Acad Sci U S A (2012) 1.80

Cytokine stimulation of aerobic glycolysis in hematopoietic cells exceeds proliferative demand. FASEB J (2004) 1.79

The potential for isocitrate dehydrogenase mutations to produce 2-hydroxyglutarate depends on allele specificity and subcellular compartmentalization. J Biol Chem (2012) 1.79

Uncoupling protein-2 controls proliferation by promoting fatty acid oxidation and limiting glycolysis-derived pyruvate utilization. FASEB J (2007) 1.77

ATF4 regulates MYC-mediated neuroblastoma cell death upon glutamine deprivation. Cancer Cell (2012) 1.71

Phosphatidylinositol 3-kinase/Akt signaling is neither required for hypoxic stabilization of HIF-1 alpha nor sufficient for HIF-1-dependent target gene transcription. J Biol Chem (2002) 1.70

Intrinsic and extrinsic pathway signaling during neuronal apoptosis: lessons from the analysis of mutant mice. J Cell Biol (2002) 1.69

Activation and inhibition of lymphocytes by costimulation. J Clin Invest (2002) 1.69

Differential effects of rapamycin on mammalian target of rapamycin signaling functions in mammalian cells. Cancer Res (2003) 1.69

Beginnings of a signal-transduction pathway for bioenergetic control of cell survival. Trends Biochem Sci (2004) 1.67